source
- Opinion: FDA commissioner nominee Heidi Overton is ignoring the science on abortion drug“With this latest appointment, mifepristone has a new boss but an old problem,” writes Julie F. Kay, founder and CEO of Reproductive Futures.STAT · 26d ago↗ source
- STAT+: Pharmalittle: We’re reading about a reticent FDA commish nominee, a Novo deal, and morePresident Trump’s nominee to lead the FDA was grilled by senators on hot button topics like China, vaccines, and abortion accessSTAT · 26d ago↗ source
- FDA approves Eli Lilly’s weekly insulin Onswik for U.S. patients, expanding competition with NovoThe U.S. Food and Drug Administration has cleared Eli Lilly’s weekly insulin product, Onswik, for use in American patients. This marks the drug’s fourth global approval after earlier clearances in…